查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
週边液体栓塞剂市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用和地理位置
市场调查报告书
商品编码
1509785

週边液体栓塞剂市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用和地理位置

Peripheral Liquid Embolic Agents Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Geography
出版日期: | 出版商: The Insight Partners | 英文 233 Pages | 订单完成后即时交付

价格

週边液体栓塞剂市场预计将从2023年的4,042万美元成长到2031年的8,141万美元；预计2023年至2031年复合年增长率为9.1%。

週边液体栓塞剂是介入放射学手术中用于阻塞渗漏血管和畸形的物质。这些药物在註射后凝固，形成阻塞并阻止血液流向目标区域。

温度诱导相变系统和 pH 值触发栓塞剂的发展成为市场成长的趋势

液体栓塞是生物工程领域非常感兴趣的议题，特别是在周边手术中。液体栓塞剂可以穿透线圈或导管无法到达的周边、病灶或远端区域。目前使用的液体栓塞剂虽然可以满足大多数临床需求，但也有一些缺点。因此，人们开发了各种新型液体栓塞剂来改善影像特性、减少併发症、优化流动性能并实现载药能力。对其他重要材料特性的系统研究，例如相关副作用（例如毒性和黏附）、生物功能（生物相容性、生物可降解性、生物力学和生物活性）和射线不透性，对于在微量介入领域开发临床客製化的栓塞剂至关重要。

温度敏感的聚合物溶液在体内可以从溶胶注射状态转变为室温下的凝胶状态。聚(N-异丙基丙烯酰胺) (PNIPAAm) 在 32 °C 的较低临界溶解温度 (LCST) 下表现出可逆相变。根据Qian等人在《受控释放杂誌》上发表的一项研究。 2015年，聚（N-异丙基丙烯酰胺-共-丁基甲基丙烯酸酯）凝胶与碘海醇分散体用于肝癌TACE，证明可有效栓塞家兔肾动脉并持续释放阿霉素。同样，根据 Wang 等人在国家医学图书馆发表的一项研究。 2011年，壳聚醣/B-磷酸甘油（C/GP）成功闭合了兔子的肾动脉，显示其是潜在的栓塞剂。同样，赵等人。根据2011 年Wiley Online Library 发表的一项研究，还研究了用于栓塞的温度敏感的PNIPAAm-iohexol 奈米凝胶。的分层3D 凝胶网络。与週边栓塞剂碘化油相比，奈米凝胶在兔子 VX2 肝肿瘤中提供了更好的周边栓塞效果。

此外，含有热敏液体栓塞水凝胶的泊洛沙姆407（聚环氧乙烷a-聚环氧丙烷b-聚环氧乙烷a的三嵌段共聚物）已被提议用于肝癌治疗。这种由泊洛沙姆407、羟甲基纤维素、海藻酸钠和碘克沙醇(PSHI) 组成的复合水凝胶随着温度的升高呈现出两相：流动的溶胶和收缩的凝胶。值得注意的是，随着肿瘤在栓塞后消失，PSHI-Ca2+ 证明了 VX2 肝癌模型的完全闭塞。

pH敏感活性成分由于体外和生理环境之间的pH变化而经历相变。这些水凝胶会根据 pH 值而膨胀和塌陷，控制药物释放。

根据 Nguyen 等人在英国皇家化学学会发表的一项研究。 2016年，开发出PCLA-PUSSM，这是一种由聚(ε-己内酯-共-丙交酯)(PCLA)、PEG和聚(氨基甲酸酯硫化物磺胺二甲嗪)(PUSSM)组成的共聚物，用于HCC的TACE。这种可生物降解的材料载有阿霉素，并随着 pH 值的降低而表现出相变。此水凝胶成功栓塞了 VX2 兔子肿瘤模型的肝肿瘤，同时提供阿霉素的持续释放。在大鼠模型中，栓塞阻止了肿瘤的血液供应，透过缺氧创造了酸性环境并诱导乳酸性酸中毒。低pH值触发药物释放并成功抑制体内肿瘤生长。

以下列出了一些正在试验的温度敏感型和 pH 触发型液体栓塞剂：

  • 表 1. 正在试验温度敏感和 pH 触发凝胶化的液体栓塞剂

液态栓塞剂机理优势经典使用情境或试用条件

壳聚醣/B-甘油磷酸（壳聚醣/B-GP） 温度和 pH 触发凝胶化 药物传输 兔子肾动脉

丝弹性蛋白样蛋白 (SELP) 温度触发凝胶化 药物传递 兔子原发性 VX2 肝肿瘤

聚（N-异丙基丙烯酰胺-甲基丙烯酸丁酯）奈米凝胶（PIB 奈米凝胶） 温度引发凝胶 比碘油更好的栓塞 兔子原发性 VX2 肝肿瘤

泊洛沙姆 407 温度触发凝胶化 暂时性血管阻塞 犬肾动脉

泊洛沙姆 407、海藻酸钠、羟甲基纤维素、碘克沙醇和钙离子 (PSHI-Ca2+) 温度触发凝胶化 不透射线 兔子原发性 VX2 肝肿瘤

基于磺胺二甲嘧啶的水凝胶 pH 触发凝胶化 药物传递 兔子原发性 VX2 肝肿瘤

聚（氨基酯聚氨酯）嵌段聚合物 (PEAU) 温度和 pH 触发凝胶化 药物传输 兔子原发性 VX2 肝肿瘤

因此，对温度诱导相变系统和 pH 触发栓塞剂的日益关注和发展预计将在未来几年为週边液体栓塞剂市场带来新趋势。

週边液体栓塞剂市场分析是透过考虑以下细分市场进行的：类型、应用和地理位置。根据类型，週边液体栓塞剂市场分为聚合液体栓塞剂和沈淀液体栓塞剂。从应用来看，週边液体栓塞剂市场分为内漏II型、畸形、出血与创伤、静脉曲张、肿瘤、内臟动脉瘤等。

週边液体栓塞剂市场报告的范围涵盖北美（美国、加拿大和墨西哥）、欧洲（西班牙、英国、德国、法国、义大利和欧洲其他地区）、亚太地区（韩国、中国） 、日本、印度、澳洲和亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地区）。北美是全球週边液体栓塞剂市场的最大贡献者。预计 2023 年至 2031 年，亚太地区的复合年增长率将达到最高。

北美区域市场的成长归因于该地区动脉瘤、创伤等病例的增加。由于政府对解决日益增长的周边疾病担忧的支持不断增加，预计加拿大市场将会成长。由于製药业和医疗旅游业的发展，墨西哥的市场预计将成长。亚太地区週边液体栓塞剂市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。该地区的市场成长受到多种因素的推动，例如周边动脉疾病（PAD）盛行率的上升、对微创手术的需求不断增加、医院和门诊手术中心数量不断增加、市场参与者对发展中国家的日益关注以及发展亚太地区的医疗保健基础设施

疾病管制与预防中心 (CDC)、欧洲药品管理局 (EMA)、泛美卫生组织 (PAHO) 和世界卫生组织 (WHO) 是在准备外围报告时提到的几个关键的主要和次要来源液体栓塞剂市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：週边液体栓塞剂市场格局

  • 概述
  • PEST分析
  • 2023 年区域定价分析

第 5 章：週边液体栓塞剂市场 - 主要市场动态

  • 週边液体栓塞剂市场 - 主要市场动态
  • 市场驱动因素
    • 周围血管疾病的发生率上升
    • 微创手术的需求不断增加
  • 市场限制
    • 栓塞剂成本高
  • 市场机会
    • 市场参与者不断增加的策略性倡议
  • 未来的趋势
    • 温度诱导相变系统和 pH 触发栓塞剂的进展
  • 影响分析

第 6 章：週边液体栓塞剂市场 - 全球市场分析

  • 週边液体栓塞剂市场收入，2021-2031
  • 週边液体栓塞剂市场分析
  • 2023 年市场定位分析

第 7 章：週边液体栓塞剂市场分析 - 按类型

  • 聚合液体栓塞剂
  • 沉淀液体栓塞剂

第 8 章：週边液体栓塞剂市场分析 - 按应用

  • II型内漏
  • 畸形
  • 出血与创伤
  • 静脉曲张
  • 肿瘤
  • 内臟动脉瘤

第 9 章：週边液体栓塞剂市场 - 地理分析

  • 北美洲
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 10 章：产业格局

  • 概述
  • 週边液体栓塞剂市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 11 章：公司简介

  • Medtronic Plc
  • B Braun SE
  • Guerbet SA
  • Sirtex Medical Ltd
  • Balt
  • MicroVention Inc
  • Johnson & Johnson
  • GEM srl

第 12 章：附录

Product Code: TIPRE00039169

The peripheral liquid embolic agents market is expected to grow from US$ 40.42 million in 2023 to US$ 81.41 million by 2031; it is anticipated to record a CAGR of 9.1% from 2023 to 2031.

Peripheral liquid embolic agents are substances used in interventional radiology procedures to block leaking blood vessel and malformations. These agents solidify after injecting which forms plug and block the blood flow to the targeted area.

Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents Acts as a Trend for Market Growth

Liquid embolism is a topic of great interest in bioengineering, particularly in peripheral procedures. Liquid embolic agents can penetrate peripheral, nidus, or distal areas where coils or catheters cannot reach. Although currently used liquid embolic agents can meet most clinical needs, they have some shortcomings. Therefore, various novel liquid embolic agents have been developed to improve imaging characteristics, reduce complications, optimize flow performance, and achieve drug loading capability. The systematic investigation of additional important material characteristics such as associated side effects (e.g., toxicity and adhesion), biofunctional (biocompatibility, biodegradability, biomechanics, and bioactivity), and radiopacity is essential for the development of clinically tailored embolic agents in the field of minimally invasive imaging procedures.

Temperature-sensitive polymer solutions can change from a sol-injectable state to a gel state at room temperature in the body. Poly(N-isopropyl acrylamide) (PNIPAAm) exhibits a reversible phase transition in response to a lower critical solution temperature (LCST) of 32 °C. According to a study published in the Journal of Controlled Release by Qian et al. in 2015, poly(N-isopropylacrylamide-co-butylmethyl acrylate) gels with iohexol dispersions for TACE of liver cancer demonstrated effective embolization of renal arteries in rabbits and sustained release of doxorubicin. Similarly, as per a study published in the National Library of Medicine by Wang et al. in 2011, chitosan/B-glycerophosphate (C/GP) successfully closed renal arteries in rabbits, indicating to be a potential embolization agent. Likewise, Zhao et al. also investigated temperature-sensitive PNIPAAm-iohexol nano gels for embolization, according to a research study published Wiley Online Library in 2011. The hydrophobic interactions above the phase transition temperature (36.5 °C) lead to a hierarchical 3D gel network for in situ vessel casting. Compared to Lipiodol, a peripheral embolic agent, the nanogel provided better peripheral embolization in VX2 liver tumors in rabbits.

Furthermore, a poloxamer 407 (a triblock copolymer of polyethylene oxide a-polypropylene oxide b-polyethylene oxide a) containing a thermosensitive liquid embolic hydrogel has been proposed for liver cancer therapy. This composite hydrogel composed of poloxamer 407, hydroxymethyl cellulose, sodium alginate, and iodixanol (PSHI) presented two phases with increasing temperature: a flowing sol and a shrunken gel. Notably, complete occlusion of the VX2 liver cancer model was demonstrated with PSHI-Ca2+ as the tumor disappeared after embolization.

pH-sensitive active ingredients undergo a phase transition due to the pH change between the in vitro and physiological environments. These hydrogels swell and collapse in response to pH, which is used to control drug release.

As per a study published in the Royal Society of Chemistry by Nguyen et al. in 2016, PCLA-PUSSM, a copolymer consisting of poly(ε-caprolactone-co-lactide) (PCLA), PEG, and poly(urethane sulfide sulfamethazine) (PUSSM) was developed, for TACE of HCC. This biodegradable material was loaded with doxorubicin and exhibited a phase transition in response to decreasing pH. The hydrogel successfully embolized a liver tumor from a VX2 rabbit tumor model while providing a sustained release of doxorubicin. In a rat model, embolization stopped blood supply to the tumor, creating an acidic environment through hypoxia and inducing lactic acidosis. The low pH triggered drug release and successfully inhibited tumor growth in vivo.

Some of the liquid embolic agents under trial for temperature-sensitive and pH-triggered are given below:

  • Table 1. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation

Liquid Embolic Agents Mechanism Advantage Classical Usage Scenarios or Trial Conditions

Chitosan/B- glycerophosphate (chitosan/B-GP) Temperature- and pH-triggered gelation Drug delivery Renal arteries in rabbits

Silk-Elastin-Like proteins (SELPs) Temperature- triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel (PIB nanogel) Temperature- triggered gelation A better embolization than lipiodol Primary VX2 liver tumors in rabbit

Poloxamer 407 Temperature- triggered gelation Temporary vascular occlusion Renal arteries in canines

poloxamer 407, sodium alginate, hydroxymethyl cellulose, iodixanol, and calcium ions (PSHI-Ca2+) Temperature- triggered gelation Radiopacity Primary VX2 liver tumors in rabbit

Sulfamethazine-based hydrogel pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Poly(Amino Ester Urethane) block polymer (PEAU) Temperature- and pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Thus, the growing focus and developments on temperature-induced phase change systems and pH-triggered embolic agents are expected to bring new trends in the peripheral liquid embolic agents market in the coming years.

The peripheral liquid embolic agents market analysis has been carried out by considering the following segments: type, application and geography. Based on type, the peripheral liquid embolic agents market is bifurcated into polymerizing liquid embolic agents and precipitating liquid embolic agents. In terms of application, the peripheral liquid embolic agents market is classified into endoleak type II, malformations, bleedings and trauma, varicose vein, tumors, and visceral aneurysm..

The scope of the peripheral liquid embolic agents market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the biggest contributor to the global peripheral liquid embolic agents market. Asia Pacific is predicted to show the highest CAGR in the market during 2023-2031.

The North America regional market growth is attributed to the increasing cases of aneurysms, trauma, and others across the region. The market in Canada is anticipated to grow because of rising government support for addressing the increasing concerns regarding peripheral disorders. The market in Mexico is estimated to grow owing to the growing pharma industries and medical tourism. The Asia Pacific peripheral liquid embolic agents market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is driven by various factors such as the rising prevalence of peripheral artery diseases (PAD), increasing demand for minimally invasive procedures, growing number of hospitals and ambulatory surgery centers, rising focus on developing countries by market players , and developing healthcare infrastructure in Asia Pacific

Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA), The Pan American Health Organization (PAHO), and World Health Organization (WHO) are a few key primary and secondary sources referred to while preparing the report on the peripheral liquid embolic agents market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Peripheral Liquid Embolic Agents Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Regional Pricing Analysis, 2023

5. Peripheral Liquid Embolic Agents Market - Key Market Dynamics

  • 5.1 Peripheral Liquid Embolic Agents Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Incidence of Peripheral Vascular Diseases
    • 5.2.2 Increasing Demand for Minimally Invasive Procedures
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Embolization Agents
  • 5.4 Market Opportunities
    • 5.4.1 Growing Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents
  • 5.6 Impact analysis

6. Peripheral Liquid Embolic Agents Market - Global Market Analysis

  • 6.1 Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Peripheral Liquid Embolic Agents Market Analysis
  • 6.3 Market Positioning Analysis, 2023

7. Peripheral Liquid Embolic Agents Market Analysis - by Type

  • 7.1 Polymerizing Liquid Embolic Agent
    • 7.1.1 Overview
    • 7.1.2 Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Precipitating Liquid Embolic Agent
    • 7.2.1 Overview
    • 7.2.2 Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Peripheral Liquid Embolic Agents Market Analysis - by Application

  • 8.1 Endoleak Type II
    • 8.1.1 Overview
    • 8.1.2 Endoleak Type II: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Malformations
    • 8.2.1 Overview
    • 8.2.2 Malformations: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.3 Bleedings and Trauma
    • 8.3.1 Overview
    • 8.3.2 Bleedings and Trauma: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.4 Varicose Vein
    • 8.4.1 Overview
    • 8.4.2 Varicose Vein: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.5 Tumours
    • 8.5.1 Overview
    • 8.5.2 Tumours: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.6 Visceral Aneurysm
    • 8.6.1 Overview
    • 8.6.2 Visceral Aneurysm: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Peripheral Liquid Embolic Agents Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Peripheral Liquid Embolic Agents Market Overview
    • 9.1.2 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.1.2.1 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.1.2.2 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.1.2.2.1 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.1.2.2.2 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.1.2.2.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.1.2.2.4 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.1.2.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.1.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.1.3.1 Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.3.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.1.3.1.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.1.3.1.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.1.3.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.1.3.2 Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.3.2.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.1.3.2.1.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.1.3.2.1.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.1.3.2.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.2 Europe
    • 9.2.1 Europe Peripheral Liquid Embolic Agents Market Overview
    • 9.2.2 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.2.1 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.2.2.2 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.2.2.2.1 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.2.2.2.2 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.2.2.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.2.2.2.4 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.2.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.1.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.1.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.2 United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.2.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.2.1.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.2.1.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.2.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.3 France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.3.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.3.1.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.3.1.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.3.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.4 Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.4.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.4.1.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.4.1.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.4.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.5 Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.5.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.5.1.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.5.1.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.5.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.6 Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.6.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.6.1.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.6.1.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.6.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Peripheral Liquid Embolic Agents Market Overview
    • 9.3.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.3.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.3.2.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.3.2.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.3.2.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.3.2.2.4 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.3.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.3.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.1.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.1.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.2 Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.2.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.2.1.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.2.1.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.2.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.3 India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.3.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.3.1.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.3.1.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.3.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.4 Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.4.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.4.1.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.4.1.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.4.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.5 South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.5.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.5.1.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.5.1.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.5.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.6 Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.6.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.6.1.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.6.1.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.6.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.4 Middle East & Africa
    • 9.4.1 Middle East & Africa Peripheral Liquid Embolic Agents Market Overview
    • 9.4.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.4.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.4.2.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.4.2.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.4.2.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.4.2.2.4 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.4.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.4.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.1.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.1.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.4.3.2 South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.2.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.2.1.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.2.1.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.2.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.4.3.3 United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.3.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.3.1.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.3.1.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.3.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.4.3.4 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.4.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.4.1.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.4.1.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.4.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.5 South and Central America
    • 9.5.1 South and Central America Peripheral Liquid Embolic Agents Market Overview
    • 9.5.2 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.2.1 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.5.2.2 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.5.2.2.1 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.5.2.2.2 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.5.2.2.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.5.2.2.4 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.5.2.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.5.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.5.3.1.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.5.3.1.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.5.3.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.5.3.2 Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.2.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.5.3.2.1.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.5.3.2.1.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.5.3.2.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.5.3.3 Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.3.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.5.3.3.1.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.5.3.3.1.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.5.3.3.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Application

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Peripheral Liquid Embolic Agents Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 B Braun SE
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Guerbet SA
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Sirtex Medical Ltd
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Balt
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 MicroVention Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Johnson & Johnson
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 GEM srl
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Peripheral Liquid Embolic Agents Market Segmentation
  • Table 2. Regional Pricing Analysis, Price (US$)/ML, 2023
  • Table 3. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation
  • Table 4. Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 5. Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 6. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 7. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 8. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 9. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 10. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 11. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 12. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 13. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 14. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 15. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 16. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 17. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 18. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 19. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 20. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 21. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 22. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 23. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 24. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 25. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 26. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 27. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 28. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 29. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 30. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 31. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 32. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 33. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 34. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 35. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 36. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 37. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 38. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 39. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 40. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 41. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 42. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 43. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 44. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 45. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 46. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 47. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 48. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 49. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 50. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 51. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 52. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 53. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 54. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 55. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 56. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 57. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 58. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 59. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 60. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 61. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 62. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 63. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 64. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 65. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 66. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 67. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 68. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 69. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 70. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 71. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 72. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 73. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 74. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 75. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 76. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 77. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 78. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 79. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 80. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 81. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 82. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 83. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 84. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 85. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 86. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 87. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 88. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 89. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 90. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 91. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 92. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 93. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 94. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 95. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 96. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 97. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 98. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 99. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 100. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 101. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 102. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 103. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 104. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 105. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 106. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 107. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 108. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 109. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 110. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 111. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 112. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 113. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 114. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 115. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 116. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 117. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 118. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 119. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 120. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 121. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 122. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 123. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 124. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 125. Recent Inorganic Growth Strategies in the Peripheral Liquid Embolic Agents Market
  • Table 126. Recent Organic Growth Strategies in the Peripheral Liquid Embolic Agents Market
  • Table 127. Glossary of Terms, Peripheral Liquid Embolic Agents Market

List Of Figures

  • Figure 1. Peripheral Liquid Embolic Agents Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Manufacturers Market Positioning, 2023
  • Figure 6. Peripheral Liquid Embolic Agents Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Peripheral Liquid Embolic Agents Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Endoleak Type II: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 11. Malformations: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 12. Bleedings and Trauma: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Varicose Vein: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. Tumours: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 15. Visceral Aneurysm: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 16. North America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 17. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 18. North America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 19. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 20. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 21. Europe Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 22. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 23. Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 24. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 25. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 26. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 27. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 28. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 29. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 30. Asia Pacific Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 31. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 32. Asia Pacific: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 34. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 35. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 36. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 37. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 38. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 39. Middle East & Africa Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 40. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 41. Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 43. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 44. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 45. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 46. South & Central America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 47. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 48. South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 49. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 50. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 51. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 52. Growth Strategies in the Peripheral Liquid Embolic Agents Market